Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2006; 12(1): 82-88
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.82
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.82
Table 3 Characteristics of the patients entering the randomized double-blind phase of the study
| Lansoprazole (30 mg/d)(n = 17) | Lansoprazole (60 mg/d)(n = 18) | |
| Age (mean±SD) | 57.5 ± 11.9 | 52.4±10.0 |
| Gender, male (% ) | 3 (17.6) | 2 (11.1) |
| Upper endoscopy positive (%) | 4 (23.5) | 3 (16.7) |
| pH-metry positive (%) | 13 (76.5) | 10 (55.5) |
| PPI test positive (%) | 11 (64.7) | 11 (61.1) |
- Citation: Baldi F, Cappiello R, Cavoli C, Ghersi S, Torresan F, Roda E. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: A comparison between two different daily doses of lansoprazole. World J Gastroenterol 2006; 12(1): 82-88
- URL: https://www.wjgnet.com/1007-9327/full/v12/i1/82.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i1.82